Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

• Gharaibeh, Y., Lee, J., Zimin, V., Chaitanya, K., Dallan, L., Pereira, G. T. R., Vergara-Martel, A . . . Wilson, D. (2023). Prediction of Stent Under-Expansion in ...

James Fujimoto is one of the pioneers of optical coherence tomography, which has revolutionized ... and to guide interventional treatment. Intravascular OCT was pioneered by one of Fujimoto ...

They have created a novel contrast agent for intravascular optical coherence tomography (IV-OCT), a medical imaging technique. The new agent, derived from gold superclusters (AuSC), could assist ...

Angiogram, which helps view moving 3D images of blood flow to your heart Intravascular optical coherence tomography or IVOCT, views the artery from the inside out. Intravascular ultrasound ...

It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries.